Hansoh Pharmaceutical (3692) Stock Forecast
AI forecast: 3692
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Ninghtang 6 hpeh hta rai
Premium shi AI hpe 1 dai, 1 rai hte 1 hpa hpang hta a mung ai hpe 1 dai, 1 rai hte 1 hpa hpang hta a mung ai hpe shan ai.
Unlock Premium🔒 Ninghkang hpe hkum hkum hpe hta
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumNinghpaw hta mung
Hansoh Pharmaceutical is among the top 30 pharmaceutical companies in China. The company manufactures medicines and has 20 years of experience in research for the treatment of diseases, including cancer, diabetes, and nervous system disorders. By the end of 2020, the company had carried out more than 50 national research and development projects and obtained over 300 invention patents in China and abroad. It owns R&D centers in Shanghai, Changzhou, and Lianyungang (China), as well as in Maryland (United States).
